An ascorbate analog labeled with iodine-131, 6-deoxy-6-[131 I]iodo-L-ascorbic acid was prepared for evaluation as an in vivo tracer of L-ascorbic acid. The no-carrier-added radiosynthesis was conducted by nucleophilic bromine-iodine exchange between the brominated precursor and sodium [131 I]iodide in 2-pentanone at 130-1401C. HPLC purification using a reversephase column gave 6-deoxy-6-[ 131 I]iodo-L-ascorbic acid in radiochemical yield of 36-60% with high radiochemical purity and satisfactory-specific radioactivity in a total preparation time of 90 min. Biodistribution studies in fibrosarcoma-bearing mice showed a high uptake in the adrenal glands, accompanied by low activity of tumor accumulation, accumulation properties similar to previous results obtained with 14 C-labeled ascorbic acid and 6-deoxy-6-[ 18 F]fluoro-L-ascorbic acid, in spite of high level of deiodination.